Karnofsky Performance Status as A Predictive Factor for Cancer-Related Fatigue Treatment with Astragalus Polysaccharides (PG2) Injection—A Double Blind, Multi-Center, Randomized Phase IV Study

• Published in: Cancers Vol. 11; no. 2; p. 128
• Main Authors: Wang, Cheng-Hsu, Lin, Cheng-Yao, Chen, Jen-Shi, Ho, Ching-Liang, Rau, Kun-Ming, Tsai, Jo-Ting, Chang, Cheng-Shyong, Yeh, Su-Peng, Cheng, Chieh-Fang, Lai, Yuen-Liang
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 22.01.2019; MDPI
• Subjects: Adverse events; Breast cancer; Cancer; Cancer therapies; Chemotherapy; Colorectal cancer; Double-blind studies; Emergency medical care; Fatigue; Gastric cancer; Injection; Lung cancer; Patients; Pharmacovigilance; Polysaccharides; Quality of life; fatigue; cancer; eywords: astragalus polysaccharides; palliative care; KPS

Fatigue is a common and debilitating symptom in patients with advanced cancer, resulting in poor quality of life and reduced treatment efficacy. Phytotherapeutic agents have shown potential effects to relieve cancer-related fatigue in these patients. The aim of this study was to evaluate the efficac...